InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics

The Quick Take
Shares expected to trade on Nasdaq under the ticker symbol "MTRI" commencing November 9, 2026 VANCOUVER, BC, Nov. 6, 2026 /PRNewswire/ -- InMed Pharmaceuticals Inc. (which has changed its name to Mentari Therapeutics, Inc.) (NASDAQ: INM) ("Mentari" or the "Company") today announced the...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Musk cites Alphabet conflicts as Google executive leaves SpaceX board
Business
Segway Powersports stärkt Partnerschaften mit europäischen Händlern auf der EICMA 2026
MAILAND, 7. November 2026 /PRNewswire/ -- Segway Powersports, SSegways weltweit angebotene Produktlinie für leistungsstarke Powersports-Fahrzeuge auf…
Business
Ligand Pharmaceuticals director sells $90,237 in common stock
Business
